David C. Hanley's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 200,000 Class A Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 19 Nov 2025 | 200,000 | 224,000 | - | 1.9 | 374,000 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2025 | 200,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Sale of securities on an exchange or to another person at price $ 7.14 per share. | 19 Nov 2025 | 200,000 | 24,000 | - | 7.1 | 1,427,680 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | David C. Hanley | Chief Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |